125 related articles for article (PubMed ID: 33053443)
1. Myeloid differentiation factor 2 in the heart: Bench to bedside evidence for potential clinical benefits?
Sumneang N; Apaijai N; Chattipakorn SC; Chattipakorn N
Pharmacol Res; 2021 Jan; 163():105239. PubMed ID: 33053443
[TBL] [Abstract][Full Text] [Related]
2. MD2 mediates angiotensin II-induced cardiac inflammation and remodeling via directly binding to Ang II and activating TLR4/NF-κB signaling pathway.
Han J; Zou C; Mei L; Zhang Y; Qian Y; You S; Pan Y; Xu Z; Bai B; Huang W; Liang G
Basic Res Cardiol; 2017 Jan; 112(1):9. PubMed ID: 28013347
[TBL] [Abstract][Full Text] [Related]
3. Arachidonic acid inhibits inflammatory responses by binding to myeloid differentiation factor-2 (MD2) and preventing MD2/toll-like receptor 4 signaling activation.
Zhang Y; Chen H; Zhang W; Cai Y; Shan P; Wu D; Zhang B; Liu H; Khan ZA; Liang G
Biochim Biophys Acta Mol Basis Dis; 2020 May; 1866(5):165683. PubMed ID: 31953218
[TBL] [Abstract][Full Text] [Related]
4. Heme induces inflammatory injury by directly binding to the complex of myeloid differentiation protein 2 and toll-like receptor 4.
Lin J; Lin K; Huang L; Jiang Y; Ding X; Luo W; Samorodov AV; Pavlov VN; Liang G; Qian J; Wang Y
Toxicol Lett; 2022 Nov; 370():15-23. PubMed ID: 36115635
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of myeloid differentiation factor-2 attenuates obesity-induced cardiomyopathy and fibrosis.
Fang Q; Wang J; Zhang Y; Wang L; Li W; Han J; Huang W; Liang G; Wang Y
Biochim Biophys Acta Mol Basis Dis; 2018 Jan; 1864(1):252-262. PubMed ID: 28965884
[TBL] [Abstract][Full Text] [Related]
6. Recent progress in the discovery of myeloid differentiation 2 (MD2) modulators for inflammatory diseases.
Chen L; Fu W; Zheng L; Wang Y; Liang G
Drug Discov Today; 2018 Jun; 23(6):1187-1202. PubMed ID: 29330126
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin II induces kidney inflammatory injury and fibrosis through binding to myeloid differentiation protein-2 (MD2).
Xu Z; Li W; Han J; Zou C; Huang W; Yu W; Shan X; Lum H; Li X; Liang G
Sci Rep; 2017 Mar; 7():44911. PubMed ID: 28322341
[TBL] [Abstract][Full Text] [Related]
8. Macrophage-derived myeloid differentiation protein 2 plays an essential role in ox-LDL-induced inflammation and atherosclerosis.
Chen T; Huang W; Qian J; Luo W; Shan P; Cai Y; Lin K; Wu G; Liang G
EBioMedicine; 2020 Mar; 53():102706. PubMed ID: 32151799
[TBL] [Abstract][Full Text] [Related]
9. Myeloid differentiation protein 2 induced retinal ischemia reperfusion injury via upregulation of ROS through a TLR4-NOX4 pathway.
Chen H; Song Z; Ying S; Yang X; Wu W; Tan Q; Ju X; Wu W; Zhang X; Qu J; Wang Y
Toxicol Lett; 2018 Jan; 282():109-120. PubMed ID: 29111459
[TBL] [Abstract][Full Text] [Related]
10. Suppression of Toll-like receptor 4 activation by caffeic acid phenethyl ester is mediated by interference of LPS binding to MD2.
Kim SY; Koo JE; Seo YJ; Tyagi N; Jeong E; Choi J; Lim KM; Park ZY; Lee JY
Br J Pharmacol; 2013 Apr; 168(8):1933-45. PubMed ID: 23231684
[TBL] [Abstract][Full Text] [Related]
11. Danshen (Salvia miltiorrhiza) restricts MD2/TLR4-MyD88 complex formation and signalling in acute myocardial infarction-induced heart failure.
Wang X; Guo D; Li W; Zhang Q; Jiang Y; Wang Q; Li C; Qiu Q; Wang Y
J Cell Mol Med; 2020 Sep; 24(18):10677-10692. PubMed ID: 32757377
[TBL] [Abstract][Full Text] [Related]
12. Lipopolysaccharide (LPS) directly suppresses growth hormone receptor (GHR) expression through MyD88-dependent and -independent Toll-like receptor-4/MD2 complex signaling pathways.
Dejkhamron P; Thimmarayappa J; Kotlyarevska K; Sun J; Lu C; Bonkowski EL; Denson LA; Menon RK
Mol Cell Endocrinol; 2007 Aug; 274(1-2):35-42. PubMed ID: 17601656
[TBL] [Abstract][Full Text] [Related]
13. The Asp299Gly polymorphism alters TLR4 signaling by interfering with recruitment of MyD88 and TRIF.
Figueroa L; Xiong Y; Song C; Piao W; Vogel SN; Medvedev AE
J Immunol; 2012 May; 188(9):4506-15. PubMed ID: 22474023
[TBL] [Abstract][Full Text] [Related]
14. MD2 blockade prevents modified LDL-induced retinal injury in diabetes by suppressing NADPH oxidase-4 interaction with Toll-like receptor-4.
Chen H; Yan T; Song Z; Ying S; Wu B; Ju X; Yang X; Qu J; Wu W; Zhang Z; Wang Y
Exp Mol Med; 2021 Apr; 53(4):681-694. PubMed ID: 33875782
[TBL] [Abstract][Full Text] [Related]
15. The acute exposure of tetrachloro-p-benzoquinone (a.k.a. chloranil) triggers inflammation and neurological dysfunction via Toll-like receptor 4 signaling: The protective role of melatonin preconditioning.
Fu J; Xia X; Liu Z; Wang Y; Wang Y; Shi Q; Song X; Song E; Song Y
Toxicology; 2017 Apr; 381():39-50. PubMed ID: 28238930
[TBL] [Abstract][Full Text] [Related]
16. Myeloid Differentiation Protein 2 Mediates Angiotensin II-Induced Liver Inflammation and Fibrosis in Mice.
Zhang Y; Liu H; Jia W; Qi J; Zhang W; Zhang W; Liang G; Zhang Y; Chen AH
Molecules; 2019 Dec; 25(1):. PubMed ID: 31861702
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin II-induced hypertension and cardiac hypertrophy are differentially mediated by TLR3- and TLR4-dependent pathways.
Singh MV; Cicha MZ; Nunez S; Meyerholz DK; Chapleau MW; Abboud FM
Am J Physiol Heart Circ Physiol; 2019 May; 316(5):H1027-H1038. PubMed ID: 30793936
[TBL] [Abstract][Full Text] [Related]
18. MD2 activation by direct AGE interaction drives inflammatory diabetic cardiomyopathy.
Wang Y; Luo W; Han J; Khan ZA; Fang Q; Jin Y; Chen X; Zhang Y; Wang M; Qian J; Huang W; Lum H; Wu G; Liang G
Nat Commun; 2020 May; 11(1):2148. PubMed ID: 32358497
[TBL] [Abstract][Full Text] [Related]
19. Signaling of high mobility group box 1 (HMGB1) through toll-like receptor 4 in macrophages requires CD14.
Kim S; Kim SY; Pribis JP; Lotze M; Mollen KP; Shapiro R; Loughran P; Scott MJ; Billiar TR
Mol Med; 2013 May; 19(1):88-98. PubMed ID: 23508573
[TBL] [Abstract][Full Text] [Related]
20. Myeloid differentiation protein 2-dependent mechanisms in retinal ischemia-reperfusion injury.
Ren L; Tao J; Chen H; Bian Y; Yang X; Chen G; Zhang X; Liang G; Wu W; Song Z; Wang Y
Toxicol Appl Pharmacol; 2017 Feb; 317():1-11. PubMed ID: 28063877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
